These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 20377775)
1. Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort. Sun F; Tao Q; Zhan S Nephrology (Carlton); 2010 Feb; 15(1):84-92. PubMed ID: 20377775 [TBL] [Abstract][Full Text] [Related]
2. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease. Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240 [TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Lucove J; Vupputuri S; Heiss G; North K; Russell M Am J Kidney Dis; 2008 Jan; 51(1):21-8. PubMed ID: 18155529 [TBL] [Abstract][Full Text] [Related]
4. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200 [TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. Kurella M; Lo JC; Chertow GM J Am Soc Nephrol; 2005 Jul; 16(7):2134-40. PubMed ID: 15901764 [TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Ninomiya T; Kiyohara Y; Kubo M; Yonemoto K; Tanizaki Y; Doi Y; Hirakata H; Iida M Am J Kidney Dis; 2006 Sep; 48(3):383-91. PubMed ID: 16931211 [TBL] [Abstract][Full Text] [Related]
7. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Chen J; Gu D; Chen CS; Wu X; Hamm LL; Muntner P; Batuman V; Lee CH; Whelton PK; He J Nephrol Dial Transplant; 2007 Apr; 22(4):1100-6. PubMed ID: 17272313 [TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Tozawa M; Iseki C; Tokashiki K; Chinen S; Kohagura K; Kinjo K; Takishita S; Iseki K Hypertens Res; 2007 Oct; 30(10):937-43. PubMed ID: 18049025 [TBL] [Abstract][Full Text] [Related]
9. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan. Wang S; Shu Z; Tao Q; Yu C; Zhan S; Li L Nephrology (Carlton); 2011 Nov; 16(8):767-76. PubMed ID: 21854506 [TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589 [TBL] [Abstract][Full Text] [Related]
11. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651 [TBL] [Abstract][Full Text] [Related]
12. High prevalence of chronic kidney disease in La Réunion island and its association with the metabolic syndrome in the non-diabetic population: La Réunion Diabetes (REDIA) Study. Stengel B; Jaussent I; Guiserix J; Bourgeon B; Papoz L; Favier F; Diabetes Metab; 2007 Dec; 33(6):444-52. PubMed ID: 18006351 [TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and its relation to chronic kidney disease in a Southeast Asian population. Satirapoj B; Supasyndh O; Mayteedol N; Chaiprasert A; Choovichian P Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):176-83. PubMed ID: 21323181 [TBL] [Abstract][Full Text] [Related]
15. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study. Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082 [TBL] [Abstract][Full Text] [Related]
16. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Othman M; Kawar B; El Nahas AM Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231 [TBL] [Abstract][Full Text] [Related]
17. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population. Onat A; Hergenç G; Can G; Kaya Z; Yüksel H Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840 [TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults. Lee JE; Choi SY; Huh W; Kim YG; Kim DJ; Oh HY Am J Hypertens; 2007 Nov; 20(11):1189-94. PubMed ID: 17954366 [TBL] [Abstract][Full Text] [Related]
19. Obesity and metabolic syndrome-related chronic kidney disease in nondiabetic, nonhypertensive adults. Yoon YS; Park HS; Yun KE; Kim SB Metabolism; 2009 Dec; 58(12):1737-42. PubMed ID: 19615700 [TBL] [Abstract][Full Text] [Related]
20. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan. Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]